AzTrials
AzTrials

Fear of ChildbirthTOKO-EDUNCT07522814

"Educational Intervention for Tokophobia in Pregnant Women"

A study testing Educational Sessions on Tokophobia in people with Fear of Childbirth and Anxiety Disorders, run by Delta University for Science and Technology at 1 site in Egypt.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

This quasi-experimental study aims to evaluate the effectiveness of structured educational sessions on tokophobia among pregnant women. Tokophobia, defined as an intense fear of pregnancy and childbirth, can negatively affect maternal psychological well-being, coping abilities, and overall quality of life. Read more about this study

Who is it for?
Ages 18 years and older, women onlyHealthy volunteers can take part
What is being tested?
Educational Sessions on Tokophobia
Could I receive a placebo?
No, everyone receives an active treatment
How many people
50 participants
Where
1 siteEgypt
Study dates
20 Feb 2025to 15 May 2025
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • Women only
  • Healthy volunteers accepted
  • Adult, Older adult

Who may be able to join

  • Pregnant women attending antenatal clinics Age 18 years and above Willing to participate and provide informed consent

Who cannot join

  • Pregnant women with diagnosed acute psychological disorders Pregnant women who are unable to participate in educational sessions Refusal to participate in the study

Trial locations and contacts

1 site in 1 country.

Egypt1 site
  • Soad Kafafi Hospital

    Cairo, Giza Governorate, 12566

Other trials in Egypt

About this study

Official title: "Effectiveness of Educational Sessions in Reducing Tokophobia and Improving Quality of Life Among Pregnant Women: A Quasi-Experimental Study"

This quasi-experimental study aims to evaluate the effectiveness of structured educational sessions on tokophobia among pregnant women. Tokophobia, defined as an intense fear of pregnancy and childbirth, can negatively affect maternal psychological well-being, coping abilities, and overall quality of life.

A purposive sample of 50 pregnant women attending antenatal clinics at Soad Kafafi Hospital, October City, Egypt, participated in the study. Participants received a structured educational intervention consisting of five sessions addressing knowledge about tokophobia, psychological coping strategies, and lifestyle modifications to enhance well-being during pregnancy.

Read more

Data were collected before and after the intervention using validated tools, including the Tokophobia Awareness Questionnaire, Tokophobia Assessment Scale, Jalowiec Coping Scale, and WHOQOL-BREF.

The study evaluates changes in awareness levels, severity of tokophobia, coping strategies, and quality of life following the intervention. The findings are expected to provide evidence on the role of educational interventions in reducing fear of childbirth and improving maternal psychological outcomes.

Read the detailed description

Tokophobia is a severe and persistent fear of pregnancy and childbirth that can negatively affect maternal mental health, coping abilities, and overall quality of life. It is associated with increased anxiety, avoidance behaviors, and preference for unnecessary medical interventions such as cesarean delivery. Lack of knowledge and inadequate psychological support during pregnancy may exacerbate this condition.

Educational interventions have been identified as effective strategies to enhance awareness, reduce fear, and improve psychological outcomes among pregnant women. Providing structured information and coping strategies may empower women, increase their sense of control, and promote positive pregnancy experiences.

This study adopts a quasi-experimental one-group pretest-posttest design to evaluate the effectiveness of structured educational sessions on tokophobia among pregnant women attending antenatal clinics at Soad Kafafi Hospital, October City, Egypt. A purposive sample of 50 pregnant women aged 18 years and above is included in the study.

The intervention consists of five structured educational sessions, including three theoretical sessions and two practical sessions. The sessions focus on increasing awareness about tokophobia, identifying its causes and symptoms, and introducing psychological coping strategies such as relaxation techniques and stress management. Additionally, lifestyle modifications and supportive practices to enhance maternal well-being are addressed.

Data are collected before and after the intervention using validated tools, including the Tokophobia Awareness Questionnaire, Tokophobia Assessment Scale (TAS), Jalowiec Coping Scale (JCS), and WHOQOL-BREF.

The primary objective is to assess the effectiveness of the educational intervention in improving awareness and reducing tokophobia severity. Secondary outcomes include improvement in coping strategies and enhancement of quality of life.

The findings of this study may contribute to improving antenatal care practices by integrating structured educational programs targeting tokophobia, thereby supporting maternal psychological well-being and promoting positive pregnancy outcomes.

Being tested
Educational Sessions on Tokophobia
Keywords
Tokophobia, Maternal Mental Health, Quality of Life Coping Strategies, Pregnant Women, Educational Intervention
Medical subject headings
Anxiety Disorders

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Educational Sessions on TokophobiaBehavioural

    Also called Tokophobia Education Program

    A structured educational program designed to provide information about tokophobia, its causes, symptoms, and management, along with training on psychological coping strategies and supportive techniques to enhance maternal well-being.

Study groups in NCT07522814
Study groupRoleWhat they receive
Educational Intervention GroupExperimentalPregnant women who received a structured educational intervention consisting of five sessions (three theoretical and two practical) focusing on increasing awareness of tokophobia, reducing fear of childbirth, and improving coping strategies and psychological well-being.
Receives: Behavioral: Educational Sessions on Tokophobia

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Change in Tokophobia Severity Score Measured by Tokophobia Assessment Scale (TAS)

    Change in tokophobia severity scores measured using the Tokophobia Assessment Scale (TAS). The total score ranges from [MIN] to [MAX], with higher scores indicating greater severity of fear of childbirth.

    Measured: Baseline and immediately after completion of the intervention (approximately 2.5 months)

Secondary outcomes (3)
  1. Change in Tokophobia Awareness Score Measured by Tokophobia Awareness Questionnaire

    Change in awareness scores measured using the Tokophobia Awareness Questionnaire. The total score ranges from [ zero] to [23], with higher scores indicating better awareness of tokophobia.

    Measured: Baseline and immediately after intervention

  2. Change in Coping Strategies Score Measured by Jalowiec Coping Scale (JCS)

    Change in coping strategies measured using the Jalowiec Coping Scale (JCS). The total score ranges from [MIN] to [MAX], with higher scores indicating more effective coping strategies.

    Measured: Baseline and immediately after intervention

  3. Change in Quality of Life Score Measured by WHOQOL-BREF

    Change in quality of life measured using the WHOQOL-BREF questionnaire. The total score ranges from 0 to 100, with higher scores indicating better quality of life.

    Measured: Baseline and immediately after completion of the educational sessions

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted13 Apr 2026
  2. Study start20 Feb 2025
  3. Primary completion10 May 2025
  4. Study completion15 May 2025

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Other
Allocation
Not applicable
Intervention model
Single group
Model description
A single-group quasi-experimental pretest-posttest design was used to evaluate the effect of educational sessions on tokophobia among pregnant women.
Masking
None (open label)
Enrolment
50 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07522814
Sponsor's protocol ID
DU-TOKO-2025-01
Acronym
TOKO-EDU
Status last verified
Apr 2026
First submitted
4 Apr 2026
Last updated
14 Apr 2026
Results posted
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No: Individual participant data (IPD) will not be made publicly available due to privacy, confidentiality, and ethical restrictions related to the study participants.

Questions about this trial

What is this clinical trial studying?

A study testing Educational Sessions on Tokophobia in people with Fear of Childbirth and Anxiety Disorders, run by Delta University for Science and Technology at 1 site in Egypt.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 14 Apr 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Egypt. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Change in Tokophobia Severity Score Measured by Tokophobia Assessment Scale (TAS) (time frame: Baseline and immediately after completion of the intervention (approximately 2.5 months)). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 14 Apr 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in